Trademark Overview
On Monday, April 8, 2024, a trademark application was filed for LENJOYVUS with the United States Patent and Trademark Office. The USPTO has given the LENJOYVUS trademark a serial number of 98488450. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, October 21, 2024. This trademark is owned by Gilead Sciences Ireland UC. The LENJOYVUS trademark is filed in the Pharmaceutical Products category with the following description:
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders